Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Watson resubmits Oxytrol NDA for overactive bladder

Sep. 5, 2002

Tadalafil receives positive recommendation in Australia

Sep. 4, 2002

Bladder-selective potassium channel openers described by Abbott and ICAgen

Sep. 4, 2002

Pharmacodynamic and pharmacokinetic profile of fesoterodine

Sep. 4, 2002

Potential new agent for stress urinary incontinence in development at Roche Bioscience

Sep. 3, 2002

Renal vasoconstriction induced by tacrolimus in rats is prevented by low dose theophylline

Aug. 29, 2002

Verapamil is effective in the treatment of Peyronie's disease

Aug. 28, 2002

New 5-HT2C agonist and its use in erectile dysfunction discussed at ACS meeting

Aug. 23, 2002

Potassium channel openers for use in bladder overactivity presented by Abbott at ACS

Aug. 22, 2002

Pivotal Alprox-TD studies complete enrollment

Aug. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...